2Harinder S. Garewal MD, PhD,Richard Sampliner MD,David Alberts MD,Karen Steinbronn MD. Increase in ornithine decarboxylase activity associated with development of dysplasia in barrett’s esophagus[J] 1989,Digestive Diseases and Sciences(2):312~314
3[2]Fojo AT,Ueda K,Slaman DJ,et al.Expression of a multidrug-resistance gene in human tumors and tissues.Pro Natl Acad Sci USA 1987,84(1):265 ~ 266
4[3]Goldstein LT.Clinical reversal of drug resistance.Curr Probl Cancer 1995,19(2):71 ~72
5[4]Luemmen G,Goepel M,Moellhoff S,et al.Phase Ⅱ study of interferon r versus interleukin-2 and interferon-α2b in metastattic renal cell carcinoma.J Urol,1996,155 (2):455 ~ 458
6Nooter K. Multidrug resistance(mdr) genes in human cancer[J].Br J Cancer, 1991, 63:663-669.
7Yang LY, Trujillo JM, siciliano MJ, et al. Distinct P-glycoprotein expression in the two subclones simultaneously selected from a human colon carcinoma cell line by cisdiamminedchroplatinum[J]. Int J cancer, 1993, 53: 478-81.
8KerrJFR, BV.Apoptosis: Its singnificance in cancer and cancer therapy[J] .Cancer, 1994, 73(8) :2013-26.
9ArosS, SuvaH, mandai M, et al. Expression of multidrug resistance gene and localization of polycoprotein in human primary ovarian cancer[J]. Cancer Res. 1994, 54:1355-58.
10Nagata S, Golstein P. The Fan Death Factor[J]. Science, 1995;267(10) : 1449-1456.